WWQ-16134-23827
4 vaccinations
4 coded responses
44 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 841 / UT
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
-
2021-01-22
Health check-in — day 7, dose 1Feeling: Poor · Fever · Headache, Nausea, Vomiting, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-27
Survey response — day 14, dose 1MedDRA: Injection site rash, Migraine, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Migraine- existing condition but very bad occurrence with vomiting and fever. Started 8 days after vaccine. Partially reported at last check in.Rash at vaccine location. Started ten days after vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
-
2021-02-10
Dose 2 — Moderna
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-12
- 2021-02-13
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Good · Fatigue or tirednessFree text: Sore throat - mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-15
- 2021-02-16
-
2021-02-17
Health check-in — day 7, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-05-12
- 2021-08-12
-
2021-12-31
Dose 3 — Moderna
- 2022-01-12
- 2022-01-21
- 2022-01-28
- 2022-02-04
- 2022-02-16
- 2022-04-02
-
2022-07-02
Survey response — 6 months, dose 3MedDRA: Oropharyngeal pain, Pain, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat, runny nose, body achesMedDRA releases: 2024-11 · check-in free text available
-
2022-07-02
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-05
-
2022-10-03
Dose 4 — ModernaCo-administered: Flu
-
2022-10-05
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-11-07
- 2022-11-14
- 2023-01-04
-
2023-04-03
Survey response — 6 months, dose 4MedDRA: Sinusitis — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-10 | Moderna | |
| 3 | 2021-12-31 | Moderna | No |
| 4 | 2022-10-03 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-02 | Unsuccessful |
Free text
Release 2 — day 14, dose 1
Symptoms: Migraine- existing condition but very bad occurrence with vomiting and fever. Started 8 days after vaccine. Partially reported at last check in.Rash at vaccine location. Started ten days after vaccine.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat - mild
Release 12 — 6 months, dose 3
Symptoms: Sore throat, runny nose, body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release